NCT00008229View on ClinicalTrials.gov

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2000

Study Completion Date

September 30, 2001

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL

filgrastim

DRUG

melphalan

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

holmium Ho 166 DOTMP

Trial Locations (1)

98109

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00008229 - Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter